Therapeutic vaccination targeting the tumour vasculature: Figure 1

Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature

(2014) John G. Facciponte et al.   JOURNAL OF CLINICAL INVESTIGATION

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

(2012) Maddalena Arigoni et al.   ANGIOGENESIS

Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin-Positive Metastatic Human Melanoma Xenografts

(2012) M. Moschetta et al.   CANCER RESEARCH

The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel

(2012) N. Pasche et al.   CLINICAL CANCER RESEARCH

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18

(2012) Stephen E Goldstone et al.   Expert Review of Vaccines

Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies

(2012) P. A. Erba et al.   JOURNAL OF NUCLEAR MEDICINE

Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

(2012) Francesco Papadia et al.   JOURNAL OF SURGICAL ONCOLOGY

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

(2011) T. K. Eigentler et al.   CLINICAL CANCER RESEARCH

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development

(2011) Elisabeth J.M. Huijbers et al.   VACCINE

Expression of Vascular Notch Ligand Delta-Like 4 and Inflammatory Markers in Breast Cancer

(2010) Adrian M. Jubb et al.   AMERICAN JOURNAL OF PATHOLOGY

B-cell tolerance: mechanisms and implications

(2010) Antony Basten et al.   CURRENT OPINION IN IMMUNOLOGY

Vaccination against the extra domain-B of fibronectin as a novel tumor therapy

(2010) Elisabeth J. M. Huijbers et al.   FASEB JOURNAL

Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma

(2010) B K Haller et al.   ONCOGENE

Fibronectins in vascular morphogenesis

(2009) Sophie Astrof et al.   ANGIOGENESIS

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer

(2009) A M Jubb et al.   BRITISH JOURNAL OF CANCER

Costly Cancer Drugs Trigger Proposals To Modify Clinical Trial Design

(2009) C. Schmidt   JNCI-Journal of the National Cancer Institute

Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines

(2009) Maria Ringvall et al.   VACCINE

Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells

(2008) Sven Christian et al.   AMERICAN JOURNAL OF PATHOLOGY

Loading doses for costly cancer biologicals: A cause for concern or tilting at windmills?

(2008) Ivo M. Hennig et al.   EUROPEAN JOURNAL OF CANCER

Therapeutic vaccines against IgE-mediated allergies

(2008) Lars Hellman   Expert Review of Vaccines